ANDA 200794, held by Sun Pharm Inds Ltd. Pantoprazole Sodium.
As of Nov 16, 2026, ANDA 200794 (Pantoprazole Sodium), held by Sun Pharm Inds Ltd, was first approved by FDA on May 2, 2012, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 2, 2012 | Original application | Approved | None posted |
| Pantoprazole SodiumEQ 20MG BASE · tablet, delayed release;oral | Pantoprazole Sodium | Discontinued |
| Pantoprazole SodiumEQ 40MG BASE · tablet, delayed release;oral | Pantoprazole Sodium | Discontinued |
| Apr 8, 2015 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jan 2, 2015 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jan 2, 2015 | Supplement 3Labeling · Standard review | Approved | None posted |
| May 31, 2013 | Supplement 2Labeling · Standard review | Approved | None posted |
| May 31, 2013 | Supplement 1Labeling · Standard review | Approved | None posted |
| May 2, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters